Sinew Pharma (ROCO:6634) COGS-to-Revenue : 0.00 (As of Jun. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Sinew Pharma COGS-to-Revenue?

Sinew Pharma's Cost of Goods Sold for the six months ended in Jun. 2023 was NT$0.00 Mil. Its Revenue for the six months ended in Jun. 2023 was NT$0.00 Mil.

Sinew Pharma's COGS to Revenue for the six months ended in Jun. 2023 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Sinew Pharma's Gross Margin % for the six months ended in Jun. 2023 was N/A%.

Sinew Pharma COGS-to-Revenue Historical Data

The historical data trend for Sinew Pharma's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinew Pharma COGS-to-Revenue Chart

Sinew Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

COGS-to-Revenue

Get a 7-Day Free Trial

0.30

0.18

0.12

Sinew Pharma Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
COGS-to-Revenue	Get a 7-Day Free Trial												0.15	0.32	0.12	-	-

Sinew Pharma COGS-to-Revenue Calculation

Sinew Pharma's COGS to Revenue for the fiscal year that ended in Dec. 2022 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.038	/	0.328
	=	0.12

Sinew Pharma's COGS to Revenue for the quarter that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0	/	0
	=

Sinew Pharma (ROCO:6634) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Sinew Pharma's Gross Margin % for the six months ended in Jun. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0 / 0
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Sinew Pharma COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Sinew Pharma's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinew Pharma (ROCO:6634) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sinew Pharma Inc (ROCO:6634) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

C516, Building C, Number 99, Lane 130, Section 1, Yuanyuan Road, Nangang District, Taipei, TWN, 11571

Website

https://www.sinewpharma.com

Sinew Pharma Inc is a Taiwan based biopharmaceutical company. It focuses on integrated new drug research and development. The company produces liver disease treatment medicines, pain treatment drugs, animal medicines, and other products. Its product portfolio includes SNP-610, SNP-630, SNP-810, SNP-820, SNP-830 and SNP-840.

Sinew Pharma (ROCO:6634) Headlines

No Headlines